B1S.F YSB Inc.

Healthcare Pharmaceutical Retailers Frankfurt Exchange
0.3500 EUR
Close of Nov 11, 2026
0.3020 0.8062
Market cap
EUR 239M
P/E
11.7x
P/B
0.75x
ROE
6.3%
Dividend yield
4.00%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is B1S.F undervalued?

Graham number
Price0.3500
Graham value0.5623
Discount37.8%

B1S.F trades 37.8% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

YSB Inc. fundamental analysis

No fundamental analysis for YSB Inc. yet.

YSB Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About YSB Inc.

YSB Inc. operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that includes Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eL…

Full company profile